Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia

Experimental Dermatology

Volumn 22, Issue 7, 2013, Pages 496-499

  Paik, Seung Hwan ^a   Yoon, Ji Seon ^b,c   Ryu, Hyeong Ho ^a   Lee, Ji Yeon ^b,c   Shin, Chang Yup ^c   Min, Kyung Hyun ^d   Jo, Seong Jin ^a,b,c   Kim, Kyu Han ^a,b,c   Kwon, Ohsang ^a,b,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Daewoong Pharmaceutical Co Ltd   (South Korea)

Author keywords

Chemotherapy induced alopecia; Dystrophic anagen pathway; Epidermal growth factor; Primary hair recovery

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR; LIPOSOME;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSTROPHY; HAIR; HAIR FOLLICLE; HAIR GROWTH; MOUSE; NONHUMAN;

ALOPECIA; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HAIR; HAIR FOLLICLE; HUMANS; LIPOSOMES; MICE; MICE, INBRED C57BL; TIME FACTORS;

EID: 84879561132     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12182     Document Type: Article

References (20)

1. Paus R, Cotsarelis G. N Engl J Med 1999: 341: 491-497.
2. Trueb R M. Semin Cutan Med Surg 2009: 28: 11-14.
3. Pletz N, Schon M, Ziegelbauer K et al. Exp Dermatol 2012: 21: 301-304.
4. Paus R. J Dermatol 1998: 25: 793-802.
5. Chon S Y, Champion R W, Geddes E R et al. J Am Acad Dermatol 2012: 67: e37-e47.
6. Philpott M P, Kealey T. J Invest Dermatol 1994: 102: 186-191.
7. Hollis D E, Chapman R E, Panaretto B A et al. Aust J Biol Sci 1983: 36: 419-434.
8. Hollis D E, Chapman R E. J Invest Dermatol 1987: 88: 455-458.
9. Braiteh F, Kurzrock R, Johnson F M. J Clin Oncol 2008: 26: 3460-3462.
10. Vaccaro M, Pollicino A, Barbuzza O et al. Clin Exp Dermatol 2009: 34: 402-403.
11. Pascual J C, Banuls J, Belinchon I et al. Br J Dermatol 2004: 151: 1111-1112.
12. Paus R, Handjiski B, Eichmuller S et al. Am J Pathol 1994: 144: 719-734.
13. Jeon S O, Hwang H J, Oh D H et al. J Microencapsul 2012: 29: 234-241.
14. Maurer M, Handjiski B, Paus R. Am J Pathol 1997: 150: 1433-1441.
15. Muller-Rover S, Handjiski B, van der Veen C et al. J Invest Dermatol 2001: 117: 3-15.
16. Yoon S Y, Kim K T, Jo S J et al. PLoS ONE 2011: 6: e28474.
17. Hendrix S, Handjiski B, Peters E M et al. J Invest Dermatol 2005: 125: 42-51.
18. Grevelman E G, Breed W P. Ann Oncol 2005: 16: 352-358.
19. Wang J, Lu Z, Au J L. Pharm Res 2006: 23: 2505-2514.
20. Jimenez J J, Yunis A A. Cancer Res 1992: 52: 413-415.